5339-05-9

Basic information

• Product Name: N,N-dimethyl-2-(4-nitrophenyl)ethanamine
• CAS NO: 5339-05-9
• Molecular Formula: C₁₀H₁₄N₂O₂
• Molecular Weight: 194.2304
• Mol File: 5339-05-9.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 301.8°C at 760 mmHg
• Flash Point: 136.3°C
• Density: 1.113g/cm³
• Vapor Pressure: 0.00103mmHg at 25°C
• Refractive Index: 1.547
• CAS DataBase Reference: N,N-dimethyl-2-(4-nitrophenyl)ethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-dimethyl-2-(4-nitrophenyl)ethanamine(5339-05-9)
• EPA Substance Registry System: N,N-dimethyl-2-(4-nitrophenyl)ethanamine(5339-05-9)

Safety Data

• Hazardous Substances Data: 5339-05-9(Hazardous Substances Data)

Upstream product

• 937-31-5 (4-Nitrophenyl)acetylene 
• 506-59-2 N,N-dimethylammonium chloride 
• 7697-37-2 nitric acid 
• 1126-71-2 N,N-dimethylphenethylamine 
• 104-03-0 4-nitrobenzeneacetic acid 
• 50-00-0 formaldehyd 
• 24954-67-4 2-(p-nitrophenyl)ethylamine 
• 5339-26-4 (4-nitrophenyl)ethyl bromide 
• 124-40-3 dimethyl amine 
• 60-12-8 2-phenylethanol 
• 100-11-8 1-bromomethyl-4-nitro-benzene 
• 1689-16-3 dimethyl-phenethyl-amine; picrate 
• 18182-40-6 N-(trimethylsilylmethyl)dimethylamine 
• 142799-31-3 N,N-dimethyl-N-<(trimethylsilyl)methyl>-4-nitrobenzylammonium bromide 

Downstream Products

• 14352-84-2 Dimethyl-<3-methyl-buten-(2)-yl>-<2-p-tolyl-aethyl>-ammoniumchlorid 
• 14352-88-6 Dimethyl-<3-methyl-buten-(2)-yl>-<2-(4-nitro-phenyl)aethyl>-ammoniumchlorid 
• 100-13-0 4-nitrostyrene 
• 1126-71-2 N,N-dimethylphenethylamine 
• 100880-15-7 {4-[bis-(2-chloro-ethyl)-amino]-phenethyl}-dimethyl-amine 
• 62-23-7 4-nitro-benzoic acid 
• 539-15-1 N,N-dimethyltyramine 
• 14352-78-4 Dimethyl-<2-p-tolyl-aethyl>-<3-chlor-buten-(2)-yl>-ammoniumchlorid 
• 7101-10-2 (2-(p-nitrophenyl)ethyl)trimethylammonium iodide 
• 5636-52-2 4-[2-(dimethylamino)ethyl]aniline 

Relevant articles and documents

WEE1 inhibitors as well as preparation and application thereof

The invention relates to WEE1 inhibitors as well as preparation and application thereof. The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates, polymorphs or isomers thereof, and their use in the preparation of medicaments for the treatment of diseases associated with WEE1 activity.

8-ETHYL-6-(ARYL)PYRIDO [2,3-D]PYRIMIDIN-7(8H) -ONES FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS AND CANCER

Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders or neurofibromatosis. Also described herein are methods of utilizing PAK inhibitors for the treatment of cancer.

IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION

Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. Formula (I).